Antipsychotic drugs and their side-effects:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Academic Press
©1993
|
| Schriftenreihe: | Neuroscience perspectives
|
| Schlagworte: | |
| Online-Zugang: | FAW01 Volltext |
| Beschreibung: | Includes bibliographical references and index Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen This volume covers both the basic science of neuroleptic drugs and their clinical use. The pharmacology of the conventional and atypical drugs is reviewed, as well as the pharmacokinetics, effects on neuronal and synaptic structure and the contribution of brain imaging techniques to our understanding of the effects of antipsychotic drugs on brain function. The clinical indications for these agents are discussed, as well as their use in both acute and maintenance therapy in psychotic illness The advantages and disadvantages of depot preparations and the broad range of potential side-effects are also considered |
| Beschreibung: | 1 Online-Ressource (xvi, 287 pages) |
| ISBN: | 0120790351 9780120790357 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042309546 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s1993 |||| o||u| ||||||eng d | ||
| 020 | |a 0120790351 |c alk. paper |9 0-12-079035-1 | ||
| 020 | |a 9780120790357 |c alk. paper |9 978-0-12-079035-7 | ||
| 035 | |a (OCoLC)902812887 | ||
| 035 | |a (DE-599)BVBBV042309546 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615/.788 |2 20 | |
| 082 | 0 | |a 615.5 |2 12eng | |
| 245 | 1 | 0 | |a Antipsychotic drugs and their side-effects |c edited by Thomas R.E. Barnes |
| 264 | 1 | |a London |b Academic Press |c ©1993 | |
| 300 | |a 1 Online-Ressource (xvi, 287 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Neuroscience perspectives | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas | ||
| 500 | |a Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose | ||
| 500 | |a However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen | ||
| 500 | |a This volume covers both the basic science of neuroleptic drugs and their clinical use. The pharmacology of the conventional and atypical drugs is reviewed, as well as the pharmacokinetics, effects on neuronal and synaptic structure and the contribution of brain imaging techniques to our understanding of the effects of antipsychotic drugs on brain function. The clinical indications for these agents are discussed, as well as their use in both acute and maintenance therapy in psychotic illness | ||
| 500 | |a The advantages and disadvantages of depot preparations and the broad range of potential side-effects are also considered | ||
| 650 | 4 | |a Humans / Nervous system / Effects of / Drugs | |
| 650 | 4 | |a Antipsychotic Agents / pharmacology | |
| 650 | 4 | |a Antipsychotic Agents / adverse effects | |
| 650 | 4 | |a Antipsychotic Agents / therapeutic use | |
| 650 | 7 | |a Antipsychotische geneesmiddelen |2 gtt | |
| 650 | 7 | |a Bijwerkingen |2 gtt | |
| 650 | 7 | |a Drogas de abuso (complicações) |2 larpcal | |
| 650 | 7 | |a Antipsicóticos (aplicações terapêuticas) |2 larpcal | |
| 650 | 7 | |a Drogas de abuso (efeitos) |2 larpcal | |
| 650 | 7 | |a Antipsicóticos (farmacologia) |2 larpcal | |
| 650 | 7 | |a Psychotropic drugs / Complications |2 fast | |
| 650 | 7 | |a Psychotropic drugs / Side effects |2 fast | |
| 650 | 4 | |a Psychotropic drugs |x Side effects | |
| 650 | 4 | |a Psychotropic drugs |x Complications | |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 0 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Barnes, Thomas R. E. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780120790357 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027746538 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://www.sciencedirect.com/science/book/9780120790357 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804152897122861056 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042309546 |
| collection | ZDB-33-ESD |
| ctrlnum | (OCoLC)902812887 (DE-599)BVBBV042309546 |
| dewey-full | 615/.788 615.5 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.788 615.5 |
| dewey-search | 615/.788 615.5 |
| dewey-sort | 3615 3788 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04238nmm a2200649zc 4500</leader><controlfield tag="001">BV042309546</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0120790351</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-12-079035-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780120790357</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-0-12-079035-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)902812887</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042309546</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.788</subfield><subfield code="2">20</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.5</subfield><subfield code="2">12eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antipsychotic drugs and their side-effects</subfield><subfield code="c">edited by Thomas R.E. Barnes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Academic Press</subfield><subfield code="c">©1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvi, 287 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neuroscience perspectives</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This volume covers both the basic science of neuroleptic drugs and their clinical use. The pharmacology of the conventional and atypical drugs is reviewed, as well as the pharmacokinetics, effects on neuronal and synaptic structure and the contribution of brain imaging techniques to our understanding of the effects of antipsychotic drugs on brain function. The clinical indications for these agents are discussed, as well as their use in both acute and maintenance therapy in psychotic illness</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The advantages and disadvantages of depot preparations and the broad range of potential side-effects are also considered</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Humans / Nervous system / Effects of / Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents / pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents / adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsychotische geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bijwerkingen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogas de abuso (complicações)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsicóticos (aplicações terapêuticas)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogas de abuso (efeitos)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsicóticos (farmacologia)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychotropic drugs / Complications</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychotropic drugs / Side effects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnes, Thomas R. E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780120790357</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027746538</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780120790357</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV042309546 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:18:00Z |
| institution | BVB |
| isbn | 0120790351 9780120790357 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027746538 |
| oclc_num | 902812887 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (xvi, 287 pages) |
| psigel | ZDB-33-ESD ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Academic Press |
| record_format | marc |
| series2 | Neuroscience perspectives |
| spelling | Antipsychotic drugs and their side-effects edited by Thomas R.E. Barnes London Academic Press ©1993 1 Online-Ressource (xvi, 287 pages) txt rdacontent c rdamedia cr rdacarrier Neuroscience perspectives Includes bibliographical references and index Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen This volume covers both the basic science of neuroleptic drugs and their clinical use. The pharmacology of the conventional and atypical drugs is reviewed, as well as the pharmacokinetics, effects on neuronal and synaptic structure and the contribution of brain imaging techniques to our understanding of the effects of antipsychotic drugs on brain function. The clinical indications for these agents are discussed, as well as their use in both acute and maintenance therapy in psychotic illness The advantages and disadvantages of depot preparations and the broad range of potential side-effects are also considered Humans / Nervous system / Effects of / Drugs Antipsychotic Agents / pharmacology Antipsychotic Agents / adverse effects Antipsychotic Agents / therapeutic use Antipsychotische geneesmiddelen gtt Bijwerkingen gtt Drogas de abuso (complicações) larpcal Antipsicóticos (aplicações terapêuticas) larpcal Drogas de abuso (efeitos) larpcal Antipsicóticos (farmacologia) larpcal Psychotropic drugs / Complications fast Psychotropic drugs / Side effects fast Psychotropic drugs Side effects Psychotropic drugs Complications Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 s Arzneimittelnebenwirkung (DE-588)4003134-2 s 1\p DE-604 Barnes, Thomas R. E. Sonstige oth http://www.sciencedirect.com/science/book/9780120790357 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Antipsychotic drugs and their side-effects Humans / Nervous system / Effects of / Drugs Antipsychotic Agents / pharmacology Antipsychotic Agents / adverse effects Antipsychotic Agents / therapeutic use Antipsychotische geneesmiddelen gtt Bijwerkingen gtt Drogas de abuso (complicações) larpcal Antipsicóticos (aplicações terapêuticas) larpcal Drogas de abuso (efeitos) larpcal Antipsicóticos (farmacologia) larpcal Psychotropic drugs / Complications fast Psychotropic drugs / Side effects fast Psychotropic drugs Side effects Psychotropic drugs Complications Psychopharmakon (DE-588)4047729-0 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| subject_GND | (DE-588)4047729-0 (DE-588)4003134-2 |
| title | Antipsychotic drugs and their side-effects |
| title_auth | Antipsychotic drugs and their side-effects |
| title_exact_search | Antipsychotic drugs and their side-effects |
| title_full | Antipsychotic drugs and their side-effects edited by Thomas R.E. Barnes |
| title_fullStr | Antipsychotic drugs and their side-effects edited by Thomas R.E. Barnes |
| title_full_unstemmed | Antipsychotic drugs and their side-effects edited by Thomas R.E. Barnes |
| title_short | Antipsychotic drugs and their side-effects |
| title_sort | antipsychotic drugs and their side effects |
| topic | Humans / Nervous system / Effects of / Drugs Antipsychotic Agents / pharmacology Antipsychotic Agents / adverse effects Antipsychotic Agents / therapeutic use Antipsychotische geneesmiddelen gtt Bijwerkingen gtt Drogas de abuso (complicações) larpcal Antipsicóticos (aplicações terapêuticas) larpcal Drogas de abuso (efeitos) larpcal Antipsicóticos (farmacologia) larpcal Psychotropic drugs / Complications fast Psychotropic drugs / Side effects fast Psychotropic drugs Side effects Psychotropic drugs Complications Psychopharmakon (DE-588)4047729-0 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| topic_facet | Humans / Nervous system / Effects of / Drugs Antipsychotic Agents / pharmacology Antipsychotic Agents / adverse effects Antipsychotic Agents / therapeutic use Antipsychotische geneesmiddelen Bijwerkingen Drogas de abuso (complicações) Antipsicóticos (aplicações terapêuticas) Drogas de abuso (efeitos) Antipsicóticos (farmacologia) Psychotropic drugs / Complications Psychotropic drugs / Side effects Psychotropic drugs Side effects Psychotropic drugs Complications Psychopharmakon Arzneimittelnebenwirkung |
| url | http://www.sciencedirect.com/science/book/9780120790357 |
| work_keys_str_mv | AT barnesthomasre antipsychoticdrugsandtheirsideeffects |